FRESNO, Calif., April 15 /PRNewswire/ -- Chairman & CEO, Paul Willis stated, "Just like his previous career at a large agribusiness company, Dr. Mark E. Whitacre has risen fast at Cypress Systems, Inc, last month being named the company's chief operating officer and president of operations." Now Cypress and Whitacre are focusing their energy on an aggressive cancer prevention campaign in order to get Americans -- and people around the world -- to consume a special type of selenium known as SelenoExcell(R). SelenoExcell(R) was found in a gold-standard human clinical trial to dramatically reduce colon, prostate, and lung cancers.
*(PHOTO 72dpi: Send2Press.com/mediaboom/08-0415-Whitacre_72dpi.jpg)
*(Photo Caption: Dr. Mark E. Whitacre.)
Mark Whitacre is the subject of a motion picture to be filmed starting next month, titled, "The Informant," with box office mega star Matt Damon playing Whitacre. However, Whitacre's real mission in life and main passion for the future is focused on the role of selenium and SelenoExcell(R) as a cancer prevention agent. Cypress believes that with the anticipated media coverage related to the movie, there will be a window of opportunity to raise public awareness for SelenoExcell(R) and cancer prevention.
Awarded his Ph.D. at Cornell University, Dr. Whitacre did his research thesis on the biochemical role of selenium at the cellular level. His research was conducted jointly with a world-renowned selenium scientist, Dr. G.F. Combs, Jr. Dr. Whitacre today stated, "Although sadly underutilized, selenium has the potential to have the most profound impact upon dietary cancer prevention of any nutrient we know of today."
Cancer rates per 100,000 people are about the same as they were 40
years ago! According to the American Cancer Society, 565,650 people are
expected to die this year due to cancer in the USA, and 1,437,180 people
are expected to have cancer in 2008. "These cancer incidence and death rate
|SOURCE Cypress Systems, Inc.|
Copyright©2008 PR Newswire.
All rights reserved